α-Viniferin-Induced Apoptosis through Downregulation of SIRT1 in Non-Small Cell Lung Cancer Cells.
Cheng HuangZi-Jun LinJui-Chieh ChenHao-Jun ZhengYu-Heng LaiHsiu-Chen HuangPublished in: Pharmaceuticals (Basel, Switzerland) (2023)
α-Viniferin, a natural stilbene compound found in plants and a polymer of resveratrol, had demonstrated potential anti-cancer and anti-inflammatory effects. However, the specific mechanisms underlying its anti-cancer activity were not yet fully understood and required further investigation. This study evaluated the effectiveness of α-viniferin and ε-viniferin using MTT assay. Results showed that α-viniferin was more effective than ε-viniferin in reducing the viability of NCI-H460 cells, a type of non-small cell lung cancer. Annexin V/7AAD assay results provided further evidence that the decrease in cell viability observed in response to α-viniferin treatment was due to the induction of apoptosis in NCI-H460 cells. The present findings indicated that treatment with α-viniferin could stimulate apoptosis in cells by cleaving caspase 3 and PARP. Moreover, the treatment reduced the expression of SIRT1, vimentin, and phosphorylated AKT, and also induced AIF nuclear translocation. Furthermore, this research provided additional evidence for the effectiveness of α-viniferin as an anti-tumor agent in nude mice with NCI-H460 cell xenografts. As demonstrated by the TUNEL assay results, α-viniferin promoted apoptosis in NCI-H460 cells in nude mice.
Keyphrases
- induced apoptosis
- endoplasmic reticulum stress
- cell cycle arrest
- oxidative stress
- signaling pathway
- cell death
- pi k akt
- randomized controlled trial
- diabetic rats
- dna damage
- cell therapy
- single cell
- cell proliferation
- high throughput
- systematic review
- metabolic syndrome
- stem cells
- risk assessment
- dna repair
- poor prognosis
- skeletal muscle
- replacement therapy
- long non coding rna
- adipose tissue
- high glucose